News blog

WHO’s HIV recommendations updates

AIDS.jpg

The World Health Organisation (WHO) has recommended that the most widely used HIV anti-retroviral treatment be phased out (Reuters, BBC).

The advice to phase out the use of stavudine comes as part of the WHO’s revamped advice for treating HIV on the eve of World AIDS day (press release). That advice includes starting anti-retroviral sooner in adults and adolescents, and for the first time WHO recommends that HIV-positive breast-feeding mothers take anti-retrovirals to try and stop infants being infected.

Mothers infected with HIV are also now recommended to begin taking anti-retrovirals earlier in their pregnancy (previously it was recommended that HIV-positive mothers started taking the drugs in their third trimester to stop the infection being transmitted to the child). The new recommendations say that the anti-retrovirals should be taken from the 14th week and until the end of the breast feeding period. “We are sending a clear message that breastfeeding is a good option for every baby, even those with HIV-positive mothers, when they have access to ARVs," says Daisy Mafubelu, WHO’s Assistant Director General for Family and Community Health.

The recommendation that stavudine be phased out was made because of long term and irreversible side effects that the drug causes, including wasting and neurological problems. Other drugs exist that do the same job without side effects, and in the developed world stavudine is not widely used. But it’s cheap and widely available, making it more popular in developing countries.

The recommendations will lead to more people needing treatment, says the WHO, but justifies this saying: “The associated costs of earlier treatment may be offset by decreased hospital costs, increased productivity due to fewer sick days, fewer children orphaned by AIDS and a drop in HIV infections.”

According to WHO, 33.4 million people are living with HIV/AIDS, with 2.7 million new infections each year. Globally, HIV/AIDS is the leading cause of death for women of reproductive age.

Image: Punchstock

Comments

  1. Report this comment

    LOUBOUTIN said:

    One of the most innovative research directions for treating malaria lies unexplored. A few years ago, Balestra et al discovered that simple oxygen breathing can stimulate the body’s production of EPO (the hormone of red blood cell production). Since then, this technique has already been used to treat the anemia of chemotherapy in one patient in one published account. It’s possible this could treat deadly malarial anemia for mere pennies and save a great many lives each year, but so far no one has found funding for even a small, inexpensive trial in Africa. The Gates Foundation may be innovative, but they have old-style gatekeepers that keep non-drug, not-invented-in-USA ideas like this from ever reaching a funding committee.

Comments are closed.